The global Betahistine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Betahistine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
8mg
25mg
Others
Segment by Application
Cerebral Thrombosis
Cerebral Embolism
Others
The Betahistine market is analysed and market size information is provided by regions (countries). Segment by Application, the Betahistine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
TOWA PHARMACEUTICAL CO., LTD
Nichi-Iko Pharmaceutical
Takeda Pharmaceutical Company Limited
EA Pharma Co., Ltd.
Disphar International B.V.
HENNIG ARZNEIMITTEL GmbH & Co. KG
DOC Generici
Ciclum Farma Unipessoal
Mylan
Orion Corporation
1 Betahistine Market Overview 1.1 Betahistine Product Scope 1.2 Betahistine Segment by Type1.2.1 Global Betahistine Sales by Type (2016 & 2021 & 2027) 1.2.2 8mg 1.2.3 25mg 1.2.4 Others 1.3 Betahistine Segment by Application1.3.1 Global Betahistine Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Cerebral Thrombosis 1.3.3 Cerebral Embolism 1.3.4 Others 1.4 Betahistine Market Estimates and Forecasts (2016-2027)1.4.1 Global Betahistine Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Betahistine Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Betahistine Price Trends (2016-2027) 2 Betahistine Estimates and Forecasts by Region 2.1 Global Betahistine Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Betahistine Retrospective Market Scenario by Region (2016-2021)2.2.1 Global Betahistine Sales Market Share by Region (2016-2021) 2.2.2 Global Betahistine Revenue Market Share by Region (2016-2021) 2.3 Global Betahistine Market Estimates and Forecasts by Region (2022-2027)2.3.1 Global Betahistine Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Betahistine Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures2.4.1 North America Betahistine Estimates and Projections (2016-2027) 2.4.2 Europe Betahistine Estimates and Projections (2016-2027) 2.4.3 China Betahistine Estimates and Projections (2016-2027) 2.4.4 Japan Betahistine Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Betahistine Estimates and Projections (2016-2027) 2.4.6 India Betahistine Estimates and Projections (2016-2027) 3 Global Betahistine Competition Landscape by Players 3.1 Global Top Betahistine Players by Sales (2016-2021) 3.2 Global Top Betahistine Players by Revenue (2016-2021) 3.3 Global Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Betahistine as of 2020) 3.4 Global Betahistine Average Price by Company (2016-2021) 3.5 Manufacturers Betahistine Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Betahistine Market Size by Type 4.1 Global Betahistine Historic Market Review by Type (2016-2021)4.1.1 Global Betahistine Sales Market Share by Type (2016-2021) 4.1.2 Global Betahistine Revenue Market Share by Type (2016-2021) 4.1.3 Global Betahistine Price by Type (2016-2021) 4.2 Global Betahistine Market Estimates and Forecasts by Type (2022-2027)4.2.1 Global Betahistine Sales Forecast by Type (2022-2027) 4.2.2 Global Betahistine Revenue Forecast by Type (2022-2027) 4.2.3 Global Betahistine Price Forecast by Type (2022-2027) 5 Global Betahistine Market Size by Application 5.1 Global Betahistine Historic Market Review by Application (2016-2021)5.1.1 Global Betahistine Sales Market Share by Application (2016-2021) 5.1.2 Global Betahistine Revenue Market Share by Application (2016-2021) 5.1.3 Global Betahistine Price by Application (2016-2021) 5.2 Global Betahistine Market Estimates and Forecasts by Application (2022-2027)5.2.1 Global Betahistine Sales Forecast by Application (2022-2027) 5.2.2 Global Betahistine Revenue Forecast by Application (2022-2027) 5.2.3 Global Betahistine Price Forecast by Application (2022-2027) 6 North America Betahistine Market Facts & Figures 6.1 North America Betahistine Sales by Company6.1.1 North America Betahistine Sales by Company (2016-2021) 6.1.2 North America Betahistine Revenue by Company (2016-2021) 6.2 North America Betahistine Sales Breakdown by Type6.2.1 North America Betahistine Sales Breakdown by Type (2016-2021) 6.2.2 North America Betahistine Sales Breakdown by Type (2022-2027) 6.3 North America Betahistine Sales Breakdown by Application6.3.1 North America Betahistine Sales Breakdown by Application (2016-2021) 6.3.2 North America Betahistine Sales Breakdown by Application (2022-2027) 7 Europe Betahistine Market Facts & Figures 7.1 Europe Betahistine Sales by Company7.1.1 Europe Betahistine Sales by Company (2016-2021) 7.1.2 Europe Betahistine Revenue by Company (2016-2021) 7.2 Europe Betahistine Sales Breakdown by Type7.2.1 Europe Betahistine Sales Breakdown by Type (2016-2021) 7.2.2 Europe Betahistine Sales Breakdown by Type (2022-2027) 7.3 Europe Betahistine Sales Breakdown by Application7.3.1 Europe 131 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 131 Sales Breakdown by Application (2022-2027) 8 China Betahistine Market Facts & Figures 8.1 China Betahistine Sales by Company8.1.1 China Betahistine Sales by Company (2016-2021) 8.1.2 China Betahistine Revenue by Company (2016-2021) 8.2 China Betahistine Sales Breakdown by Type8.2.1 China Betahistine Sales Breakdown by Type (2016-2021) 8.2.2 China Betahistine Sales Breakdown by Type (2022-2027) 8.3 China Betahistine Sales Breakdown by Application8.3.1 China 240 Sales Breakdown by Application (2016-2021) 8.3.2 China 240 Sales Breakdown by Application (2022-2027) 9 Japan Betahistine Market Facts & Figures 9.1 Japan Betahistine Sales by Company9.1.1 Japan Betahistine Sales by Company (2016-2021) 9.1.2 Japan Betahistine Revenue by Company (2016-2021) 9.2 Japan Betahistine Sales Breakdown by Type9.2.1 Japan Betahistine Sales Breakdown by Type (2016-2021) 9.2.2 Japan Betahistine Sales Breakdown by Type (2022-2027) 9.3 Japan Betahistine Sales Breakdown by Application9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Betahistine Market Facts & Figures 10.1 Southeast Asia Betahistine Sales by Company10.1.1 Southeast Asia Betahistine Sales by Company (2016-2021) 10.1.2 Southeast Asia Betahistine Revenue by Company (2016-2021) 10.2 Southeast Asia Betahistine Sales Breakdown by Type10.2.1 Southeast Asia Betahistine Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Betahistine Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Betahistine Sales Breakdown by Application10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Betahistine Market Facts & Figures 11.1 India Betahistine Sales by Company11.1.1 India Betahistine Sales by Company (2016-2021) 11.1.2 India Betahistine Revenue by Company (2016-2021) 11.2 India Betahistine Sales Breakdown by Type11.2.1 India Betahistine Sales Breakdown by Type (2016-2021) 11.2.2 India Betahistine Sales Breakdown by Type (2022-2027) 11.3 India Betahistine Sales Breakdown by Application11.3.1 India Betahistine Sales Breakdown by Application (2016-2021) 11.3.2 India Betahistine Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Betahistine Business 12.1 TOWA PHARMACEUTICAL CO., LTD12.1.1 TOWA PHARMACEUTICAL CO., LTD Corporation Information 12.1.2 TOWA PHARMACEUTICAL CO., LTD Business Overview 12.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Products Offered 12.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Development 12.2 Nichi-Iko Pharmaceutical12.2.1 Nichi-Iko Pharmaceutical Corporation Information 12.2.2 Nichi-Iko Pharmaceutical Business Overview 12.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Nichi-Iko Pharmaceutical Betahistine Products Offered 12.2.5 Nichi-Iko Pharmaceutical Recent Development 12.3 Takeda Pharmaceutical Company Limited12.3.1 Takeda Pharmaceutical Company Limited Corporation Information 12.3.2 Takeda Pharmaceutical Company Limited Business Overview 12.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Takeda Pharmaceutical Company Limited Betahistine Products Offered 12.3.5 Takeda Pharmaceutical Company Limited Recent Development 12.4 EA Pharma Co., Ltd.12.4.1 EA Pharma Co., Ltd. Corporation Information 12.4.2 EA Pharma Co., Ltd. Business Overview 12.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.4.4 EA Pharma Co., Ltd. Betahistine Products Offered 12.4.5 EA Pharma Co., Ltd. Recent Development 12.5 Disphar International B.V.12.5.1 Disphar International B.V. Corporation Information 12.5.2 Disphar International B.V. Business Overview 12.5.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Disphar International B.V. Betahistine Products Offered 12.5.5 Disphar International B.V. Recent Development 12.6 HENNIG ARZNEIMITTEL GmbH & Co. KG12.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information 12.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview 12.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Products Offered 12.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development 12.7 DOC Generici12.7.1 DOC Generici Corporation Information 12.7.2 DOC Generici Business Overview 12.7.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.7.4 DOC Generici Betahistine Products Offered 12.7.5 DOC Generici Recent Development 12.8 Ciclum Farma Unipessoal12.8.1 Ciclum Farma Unipessoal Corporation Information 12.8.2 Ciclum Farma Unipessoal Business Overview 12.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Ciclum Farma Unipessoal Betahistine Products Offered 12.8.5 Ciclum Farma Unipessoal Recent Development 12.9 Mylan12.9.1 Mylan Corporation Information 12.9.2 Mylan Business Overview 12.9.3 Mylan Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Mylan Betahistine Products Offered 12.9.5 Mylan Recent Development 12.10 Orion Corporation12.10.1 Orion Corporation Corporation Information 12.10.2 Orion Corporation Business Overview 12.10.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Orion Corporation Betahistine Products Offered 12.10.5 Orion Corporation Recent Development 13 Betahistine Manufacturing Cost Analysis 13.1 Betahistine Key Raw Materials Analysis13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Betahistine 13.4 Betahistine Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Betahistine Distributors List 14.3 Betahistine Customers 15 Market Dynamics 15.1 Betahistine Market Trends 15.2 Betahistine Drivers 15.3 Betahistine Market Challenges 15.4 Betahistine Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List
Summary: Get latest Market Research Reports on Betahistine. Industry analysis & Market Report on Betahistine is a syndicated market report, published as Global Betahistine Sales Market Report 2021. It is complete Research Study and Industry Analysis of Betahistine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 20 June, 2021